Chantal Pharmaceutical announces new chief financial officer.LOS ANGELES--(BUSINESS WIRE)--June 25, 1996--Chantal Pharmaceutical Corporation (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CHTL) today announced that an agreement has been reached with Gary D. Burnison to become the company's chief financial officer. He will officially join the company on July 8, 1996. Chantal Burnison, chairman and chief executive officer, stated that Burnison (who is not related to Ms. Burnison) brings more than 12 years of public accounting and broad-based business and financial management skills to the company. "The addition of Mr. Burnison to our management team affirms our commitment to build a strong company as it continues its rapid growth," said Ms. Burnison, who noted that this is the second appointment the company has made in recent days to strengthen both the board and management. "Our new Chief Financial Officer will be a key member of our management team, applying his comprehensive financial, investor and public company experience to help the company set strategy and position itself for both domestic and international growth." Burnison was recently a senior vice president at Jefferies & Company, an international investment banking and brokerage firm, and prior to that was a partner of KPMG KPMG Klynveld Peat Marwick Goerdeler (accounting firm) KPMG Kaiser Permanente Medical Group KPMG Keiner Prüft Mehr Genau (German) KPMG Kommen Prüfen Meckern Gehen Peat Marwick, an international accounting, consulting and tax firm. Chantal Pharmaceutical Corporation has executive offices, telemarketing and warehouse facilities in Los Angeles, with a laboratory in Kaiserslautern, Germany. In addition to marketing the Chantal Ethocyn Skin Care line, the company is engaged in the research and development of products for androgen androgen (ăn`drəjən): see testosterone. androgen Any of a group of hormones that mainly influence the development of the male reproductive system. mediated disorders such as acne, hirsutism Hirsutism Definition Excessive growth of facial or body hair in women is called hirsutism. Description Hirsutism is not a disease. The condition usually develops during puberty and becomes more pronounced as the years go by. , male pattern baldness male pattern baldness n. A progressive, diffuse loss of scalp hair in men that begins in the twenties or early thirties, depends on the presence of the androgenic hormone testosterone, and is caused by a combination of genetic and hormonal factors. , benign prostate hypertrophy hypertrophy (hīpûr`trəfē), enlargement of a tissue or organ of the body resulting from an increase in the size of its cells. Such growth accompanies an increase in the functioning of the tissue. and the treatment of certain cancers. CONTACT: Martin E. Janis & Company, Inc. Bev Jedynak, 312/943-1100 |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion